Charlie Rodi
Directeur Général chez Rhodx, Inc.
Profil
Charlie Rodi is the founder of Rhodx, Inc. He worked as an Executive Vice President-Genomics at Sequenom, Inc. from 1999 to 2002.
He was also the Chief Technology Officer & Vice President at Cardiff Oncology, Inc. He worked as a Vice President-Research & Development at Sorrento Therapeutics, Inc. from 2009 to 2011.
Dr. Rodi holds a doctorate degree from the University of Minnesota.
Postes actifs de Charlie Rodi
| Sociétés | Poste | Début |
|---|---|---|
Rhodx, Inc.
 Rhodx, Inc. Miscellaneous Commercial ServicesCommercial Services Rhodx, Inc. is a technology company based in St. Louis, MO. Rhodx is developing solutions to improve detection and characterization of cancer through their technology overview which includes PointsSuppressor™ - wild type suppression and NexGenAble™ - mutation detection services. The company is focused on the next generation of liquid biopsy. The company was founded by Charlie Rodi and he has been the CEO since incorporation. | Directeur Général | - |
Anciens postes connus de Charlie Rodi
| Sociétés | Poste | Fin |
|---|---|---|
| SORRENTO THERAPEUTICS, INC. | Corporate Officer/Principal | 01/01/2011 |
| SEQUENOM, INC. | Corporate Officer/Principal | 01/01/2002 |
| CARDIFF ONCOLOGY, INC. | Directeur Technique/Scientifique/R&D | - |
Formation de Charlie Rodi
| University of Minnesota | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| CARDIFF ONCOLOGY, INC. | Health Technology |
| SORRENTO THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Sequenom, Inc.
 Sequenom, Inc. Medical SpecialtiesHealth Technology Sequenom, Inc. engages in the provision of early patient management information. It develops and commercializes molecular diagnostic testing services that serve women's health and oncology markets. The company was founded by Hubert Koester and Charles R. Cantor in October 09, 1996 and is headquartered in Burlington, NC. | Health Technology |
Rhodx, Inc.
Rhodx, Inc. Miscellaneous Commercial ServicesCommercial Services Rhodx, Inc. is a technology company based in St. Louis, MO. Rhodx is developing solutions to improve detection and characterization of cancer through their technology overview which includes PointsSuppressor™ - wild type suppression and NexGenAble™ - mutation detection services. The company is focused on the next generation of liquid biopsy. The company was founded by Charlie Rodi and he has been the CEO since incorporation. | Commercial Services |
